Stay updated on Galcanezumab for Vestibular Migraine Clinical Trial
Sign up to get notified when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.

Latest updates to the Galcanezumab for Vestibular Migraine Clinical Trial page
- Check3 days agoChange DetectedThe record history now includes a new revision entry (v3.3.4) and removes the previous entry (v3.3.3), reflecting administrative version tracking. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision entry (v3.3.3) was added to the record history, and an older revision (v3.3.2) along with the HHS Vulnerability Disclosure footer link were removed; these are metadata updates to the record history and do not affect the study's data or outcomes.SummaryDifference0.2%

- Check54 days agoChange DetectedA new revision tag (v3.3.2) was added to the record history, replacing the previous v3.2.0. This is a metadata update and does not change study details or results.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the notice about lapse in government funding and NIH operating status from the page.SummaryDifference0.7%

- Check75 days agoChange DetectedVersion 10 (2024-11-15) updates the record with revised Study Status and adds Outcome Measures, Baseline Characteristics, and Adverse Events sections to the study record.SummaryDifference0.1%

- Check103 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference12%

Stay in the know with updates to Galcanezumab for Vestibular Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.